These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16301287)

  • 1. Treatment of postoperative nausea and vomiting with dolasetron versus ondansetron: is there a conflict of interest?
    White PF
    Anesth Analg; 2005 Dec; 101(6):1887. PubMed ID: 16301287
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethics, marketing, and the medical literature.
    Mychaskiw G; Badr AE; Calimaran AM
    Anesth Analg; 2006 Aug; 103(2):488; discussion 488; author reply 488-9. PubMed ID: 16861440
    [No Abstract]   [Full Text] [Related]  

  • 3. Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting.
    Meyer TA; Roberson CR; Rajab MH; Davis J; McLeskey CH
    Anesth Analg; 2005 Feb; 100(2):373-377. PubMed ID: 15673860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.
    Sukhani R; Pappas AL; Lurie J; Hotaling AJ; Park A; Fluder E
    Anesth Analg; 2002 Nov; 95(5):1230-5, table of contents. PubMed ID: 12401599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children.
    Karamanlioglu B; Turan A; Memis D; Süt N
    Eur J Anaesthesiol; 2003 Oct; 20(10):831-5. PubMed ID: 14580054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures.
    Browning BA; Fort CA; Kemp KD; Shimata MF; Strube MD
    AANA J; 2004 Apr; 72(2):129-32. PubMed ID: 15098526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting.
    Walker JB
    Clin Ther; 2001 Jun; 23(6):932-8. PubMed ID: 11440292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study.
    Korttila K; Clergue F; Leeser J; Feiss P; Olthoff D; Payeur-Michel C; Wessel P; Nave S; Hahne W; Brown R
    Acta Anaesthesiol Scand; 1997 Aug; 41(7):914-22. PubMed ID: 9265937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
    Hamadani M; Awab A; Chaudhary L; Tfayli A
    J Oncol Pharm Pract; 2006 Jun; 12(2):67-8. PubMed ID: 16984743
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy and cost-effectiveness of prophylactic 5-hydroxytryptamine3 receptor antagonists: tropisetron, ondansetron and dolasetron.
    Paech MJ; Rucklidge MW; Banks SL; Gurrin LC; Orlikowski CE; Pavy TJ
    Anaesth Intensive Care; 2003 Feb; 31(1):11-7. PubMed ID: 12635388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.
    Lofters WS; Pater JL; Zee B; Dempsey E; Walde D; Moquin JP; Wilson K; Hoskins P; Guevin RM; Verma S; Navari R; Krook JE; Hainsworth J; Palmer M; Chin C
    J Clin Oncol; 1997 Aug; 15(8):2966-73. PubMed ID: 9256141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dolasetron versus ondansetron as single-agent prophylaxis for patients at increased risk for postoperative nausea and vomiting: a prospective, double-blind, randomized trial.
    Birmingham SD; Mecklenburg BW; Lujan E; Dacanay RG; Boyle PK; Green R
    Mil Med; 2006 Sep; 171(9):913-6. PubMed ID: 17036618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis.
    Zarate E; Watcha MF; White PF; Klein KW; Sa Rego M; Stewart DG
    Anesth Analg; 2000 Jun; 90(6):1352-8. PubMed ID: 10825320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of dolasetron mesilate in treatment of postoperative nausea and vomiting].
    Badaoui R; Yagoubi A; Carpentier F; Riboulot M; Ossart M
    Presse Med; 2000 May; 29(17):947. PubMed ID: 10855246
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
    Hesketh P; Navari R; Grote T; Gralla R; Hainsworth J; Kris M; Anthony L; Khojasteh A; Tapazoglou E; Benedict C; Hahne W
    J Clin Oncol; 1996 Aug; 14(8):2242-9. PubMed ID: 8708713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
    Pater JL; Lofters WS; Zee B; Dempsey E; Walde D; Moquin JP; Wilson K; Hoskins P; Guevin RM; Verma S; Navari R; Krook JE; Hainsworth J; Palmer M; Chin C
    Ann Oncol; 1997 Feb; 8(2):181-5. PubMed ID: 9093728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surrogate outcomes: meaningful not!
    Fisher DM
    Anesthesiology; 1999 Feb; 90(2):355-6. PubMed ID: 9952135
    [No Abstract]   [Full Text] [Related]  

  • 18. Dolasetron decreases postoperative nausea and vomiting after breast surgery.
    Abou Zeid H; Al-Gahamdi A; Abdul-Hadi M
    Breast J; 2002; 8(4):216-21. PubMed ID: 12100113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The addition of dexamethasone to dolasetron or haloperidol for treatment of established postoperative nausea and vomiting.
    Rüsch D; Arndt C; Martin H; Kranke P
    Anaesthesia; 2007 Aug; 62(8):810-7. PubMed ID: 17635430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative nausea and vomiting after surgery for prognathism: not only a question of patients' comfort. A placebo-controlled comparison of dolasetron and droperidol.
    Piper SN; Röhm K; Boldt J; Kranke P; Maleck W; Seifert R; Suttner S
    J Craniomaxillofac Surg; 2008 Apr; 36(3):173-179. PubMed ID: 18353666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.